Patent Application
Utility
PCT National Stage
App. No. 18/292,844
· Confirmation No. 1459
USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY
Inventor:
Volker KNAPPERTZ
Applicant:
GW Research Limited
Abandoned -- Incomplete Application (Pre-examination)
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2025-07-09 | ABN |
Abandonment | 1 | View | |
| 2025-01-23 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2024-10-04 | PEFN |
Pre-Exam Formalities Notice | 1 | View | |
| 2024-10-04 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2024-10-04 | 371.FEE.M923 |
371 (National Stage) Supplemental Fees Missing - Form M923 | 2 | View | |
| 2024-10-04 | WCLM |
Claims Worksheet (PTO-2022) | 1 | View | |
| 2024-10-04 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2024-09-23 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2024-09-23 | 371.FEE.M923 |
371 (National Stage) Supplemental Fees Missing - Form M923 | 2 | View | |
| 2024-09-23 | WCLM |
Claims Worksheet (PTO-2022) | 1 | View | |
| 2024-09-23 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2024-09-23 | WELCOME.LET |
Welcome Letter from USPTO Director and Deputy Director | 1 | View | |
| 2024-01-26 | A.PE |
Preliminary Amendment | — | View | |
| 2024-01-26 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2024-01-26 | TRNA |
Transmittal of New Application | 3 | View | |
| 2024-01-26 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2024-01-26 | PA.. |
Power of Attorney | 2 | View | |
| 2024-01-26 | ADS |
Application Data Sheet | 7 | View | |
| 2024-01-26 | A.PE |
Preliminary Amendment | 1 | View | |
| 2024-01-26 | SPEC |
Specification | 1 | View | |
| 2024-01-26 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2024-01-26 | OATH |
Oath or Declaration filed | 1 | View | |
| 2024-01-26 | P.N.101.CONV |
PCT/RO/101 - Request form for new International Application - Conventional | 6 | View | |
| 2024-01-26 | FRPR |
Certified Copy of Foreign Priority Application | 41 | View | |
| 2024-01-26 | ABST |
Abstract | 1 | View | |
| 2024-01-26 | SPEC |
Specification | 22 | View | |
| 2024-01-26 | CLM |
Claims | 3 | View | |
| 2024-01-26 | DRW |
Drawings-only black and white line drawings | 1 | View |
Inventors
Volker KNAPPERTZ
Cambridge, UNITED KINGDOM
Attorneys & Agents of Record
Classification
USPC
514/733
A61K31/658
A61P25/12
A61P25/08
Prosecution
- Art Unit
- 1629
- Customer No.
- 58249
- Docket No.
- GWPH-040/01US 329736-2357
- Confirmation No.
- 1459
Publication
- Pub. No.
- US20250025482A1
- Pub. Date
- 2025-01-23
from
CAVION, INC.,
CELATOR PHARMACEUTICALS, INC.,
GW PHARMA LIMITED,
JAZZ PHARMACEUTICALS IRELAND LIMITED,
JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (F/K/A GW RESEARCH LIMITED),
JAZZ PHARMACEUTICALS, INC.
SECURITY AGREEMENT
Recorded 2024-07-26
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 18/292,844
- Filed
- 2024-01-26
- Pub. No.
- US20250025482A1
- Art Unit
- 1629
External Links